Skip to main content
Erschienen in: European Radiology 11/2008

01.11.2008 | Hepatobiliary-Pancreas

Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla

verfasst von: F. Fischbach, T. Schirmer, M. Thormann, T. Freund, J. Ricke, H. Bruhn

Erschienen in: European Radiology | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

This comparative study of tumour patients and volunteers aimed at differentiating liver parenchyma from neoplastic lesions by using localised 1H MRS at 3.0 T as an adjunct to MRI. In total 186 single-voxel proton spectra of the liver were acquired at 3.0 T using the body transmit receive coil. Consecutive stacks of breath-hold spectra were acquired in the PRESS technique at a short echo time of 35 ms and a repetition time of 2,000 ms. Processing of the spectra included spectral alignment with the software package SAGE and quantitative processing with LCModel. The resulting metabolite concentrations were presented in arbitrary units relative to the internal water. In general, the spectra showed four main groups of resonances originating from the methyl protons (0.8–1.1 ppm) and methylene protons of the lipids (1.1–1.5 ppm; 2.0–2.2 ppm) as well as the methyl protons of choline-containing compounds (CCC) at 3.2 ppm. Overall, the CCC and lipid values in malignant liver tumours showed no significant differences to liver parenchyma. On average, total lipid measurements in normal liver parenchyma increased with age, while those of the CCC did not show pertinent changes. Significant differences between the contents of CCC in malignant liver tumours and normal liver parenchyma were not observed, because in patients and volunteers normal liver tissue showed a large variability in the content of CCC.
Literatur
1.
Zurück zum Zitat Jeong YY, Mitchell DG, Kamishima T (2002) Small (< 20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. Am J Roentgenol 178:1327–1334 Jeong YY, Mitchell DG, Kamishima T (2002) Small (< 20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. Am J Roentgenol 178:1327–1334
2.
Zurück zum Zitat Bell JD, Cox IJ, Sargentoni J, Peden CJ, Menon DK, Foster CS, Watanapa P, Iles RA, Urenjak J (1993) A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1225:71–77PubMed Bell JD, Cox IJ, Sargentoni J, Peden CJ, Menon DK, Foster CS, Watanapa P, Iles RA, Urenjak J (1993) A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1225:71–77PubMed
3.
Zurück zum Zitat Dixon RM (1998) NMR studies of phospholipid metabolism in hepatic lymphoma. NMR Biomed 11:370–379PubMedCrossRef Dixon RM (1998) NMR studies of phospholipid metabolism in hepatic lymphoma. NMR Biomed 11:370–379PubMedCrossRef
4.
Zurück zum Zitat Soper R, Himmelreich U, Painter D, Somorjai R, Lean CL, Dolenko B, Mountford CE, Russell P (2002) Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology 34:417–422PubMedCrossRef Soper R, Himmelreich U, Painter D, Somorjai R, Lean CL, Dolenko B, Mountford CE, Russell P (2002) Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology 34:417–422PubMedCrossRef
5.
Zurück zum Zitat Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0T MR scanner. J Magn Reson Imaging 19:598–604PubMedCrossRef Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0T MR scanner. J Magn Reson Imaging 19:598–604PubMedCrossRef
6.
Zurück zum Zitat Dzik-Jurasz AS, Murphy PS, George M, Prock T, Collins DJ, Swift I, Leach MO, Rowland IJ (2002) Human rectal adenocarcinoma: demonstration of 1H-MR spectra in vivo at 1.5T. Magn Reson Med 47:809–811PubMedCrossRef Dzik-Jurasz AS, Murphy PS, George M, Prock T, Collins DJ, Swift I, Leach MO, Rowland IJ (2002) Human rectal adenocarcinoma: demonstration of 1H-MR spectra in vivo at 1.5T. Magn Reson Med 47:809–811PubMedCrossRef
7.
Zurück zum Zitat Edelstein WA, Glover GH, Hardy CJ, Redington RW (1986) The intrinsic signal-to-noise ratio in NMR imaging. Magn Reson Med 3:604–618PubMedCrossRef Edelstein WA, Glover GH, Hardy CJ, Redington RW (1986) The intrinsic signal-to-noise ratio in NMR imaging. Magn Reson Med 3:604–618PubMedCrossRef
8.
Zurück zum Zitat Gonen O, Gruber S, Li BS, Mlynarik V, Moser E (2001) Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0T: signal-to-noise ratio and resolution comparison. Am J Neuroradiol 22:1727–1731PubMed Gonen O, Gruber S, Li BS, Mlynarik V, Moser E (2001) Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0T: signal-to-noise ratio and resolution comparison. Am J Neuroradiol 22:1727–1731PubMed
9.
Zurück zum Zitat Gruetter R, Weisdorf SA, Rajanayagan V, Terpstra M, Merkle H, Truwit CL, Garwood M, Nyberg SL, Ugurbil K (1998) Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 135:260–264PubMedCrossRef Gruetter R, Weisdorf SA, Rajanayagan V, Terpstra M, Merkle H, Truwit CL, Garwood M, Nyberg SL, Ugurbil K (1998) Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 135:260–264PubMedCrossRef
10.
Zurück zum Zitat Bartha R, Drost DJ, Menon RS, Williamson PC (2000) Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0Tesla. Magn Reson Med 44:185–192PubMedCrossRef Bartha R, Drost DJ, Menon RS, Williamson PC (2000) Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0Tesla. Magn Reson Med 44:185–192PubMedCrossRef
11.
Zurück zum Zitat Bartolozzi C, Cioni D, Donati F, Lencioni R (2001) Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 11:1374–1388PubMedCrossRef Bartolozzi C, Cioni D, Donati F, Lencioni R (2001) Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 11:1374–1388PubMedCrossRef
12.
Zurück zum Zitat Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679PubMedCrossRef Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679PubMedCrossRef
13.
Zurück zum Zitat Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D (2001) Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 14:278–283PubMedCrossRef Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D (2001) Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 14:278–283PubMedCrossRef
14.
Zurück zum Zitat Dagnelie PC, Sijens PE, Kraus DJ, Planting AS, van Dijk P (1999) Abnormal liver metabolism in cancer patients detected by (31)P MR spectroscopy. NMR Biomed 12:535–544PubMedCrossRef Dagnelie PC, Sijens PE, Kraus DJ, Planting AS, van Dijk P (1999) Abnormal liver metabolism in cancer patients detected by (31)P MR spectroscopy. NMR Biomed 12:535–544PubMedCrossRef
15.
Zurück zum Zitat Kreis R (1997) Quantitative localized 1H MR spectroscopy for clinical use. J Progr Nucl Magn Reson Spectroscopy 31:155–195CrossRef Kreis R (1997) Quantitative localized 1H MR spectroscopy for clinical use. J Progr Nucl Magn Reson Spectroscopy 31:155–195CrossRef
16.
Zurück zum Zitat Earls JP, Rofsky NM, Decorato DR, Krinsky GA, Weinreb JC (1999) Echo-train STIR MRI of the liver: comparison of breath-hold and non-breath-hold imaging strategies. J Magn Reson Imaging 9:87–92PubMedCrossRef Earls JP, Rofsky NM, Decorato DR, Krinsky GA, Weinreb JC (1999) Echo-train STIR MRI of the liver: comparison of breath-hold and non-breath-hold imaging strategies. J Magn Reson Imaging 9:87–92PubMedCrossRef
17.
Zurück zum Zitat Gaa J, Hatabu H, Jenkins RL, Finn JP, Edelman RR (1996) Liver masses: replacement of conventional T2-weighted spin-echo MR imaging with breath-hold MR imaging. Radiology 200:459–464PubMed Gaa J, Hatabu H, Jenkins RL, Finn JP, Edelman RR (1996) Liver masses: replacement of conventional T2-weighted spin-echo MR imaging with breath-hold MR imaging. Radiology 200:459–464PubMed
18.
Zurück zum Zitat Katz-Brull R, Rofsky NM, Lenkinski RE (2003) Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magn Reson Med 50:461–467PubMedCrossRef Katz-Brull R, Rofsky NM, Lenkinski RE (2003) Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magn Reson Med 50:461–467PubMedCrossRef
19.
Zurück zum Zitat Schirmer T, Sodickson DK, Rofsky NM, Cline H, Hardy CJ, Thormann M, Fischbach F, Bruhn H, Ricke J, Niendorf T (2005) 1H liver spectroscopy with 32-element coil arrays. In: Proceedings of the International Society of Magnetic Resonance in Medicine, Berkeley, CA, USA Schirmer T, Sodickson DK, Rofsky NM, Cline H, Hardy CJ, Thormann M, Fischbach F, Bruhn H, Ricke J, Niendorf T (2005) 1H liver spectroscopy with 32-element coil arrays. In: Proceedings of the International Society of Magnetic Resonance in Medicine, Berkeley, CA, USA
20.
Zurück zum Zitat Schirmer T, Kohler S, Gultekin D, Raidy T (2004) Simple absolute signal scaling for spectroscopic data acquired with phased-array coils at 1.5T. In: Proceedings of the International Society of Magnetic Resonance in Medicine, Berkeley, CA, USA Schirmer T, Kohler S, Gultekin D, Raidy T (2004) Simple absolute signal scaling for spectroscopic data acquired with phased-array coils at 1.5T. In: Proceedings of the International Society of Magnetic Resonance in Medicine, Berkeley, CA, USA
21.
Zurück zum Zitat Tarasow E, Siergiejczyk L, Panasiuk A, Kubas B, Dzienis W, Prokopowicz D, Walecki J (2002) MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit 8:36–40 Tarasow E, Siergiejczyk L, Panasiuk A, Kubas B, Dzienis W, Prokopowicz D, Walecki J (2002) MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit 8:36–40
22.
Zurück zum Zitat Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, Everson LI, Yee D, Garwood M (2003) In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50:1134–1143PubMedCrossRef Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, Everson LI, Yee D, Garwood M (2003) In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50:1134–1143PubMedCrossRef
23.
Zurück zum Zitat Cho SG, Kim MY, Kim HJ, Kim YS, Choi W, Shin SH, Hong KC, Kim YB, Lee JH, Suh CH (2001) Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221:740–746PubMedCrossRef Cho SG, Kim MY, Kim HJ, Kim YS, Choi W, Shin SH, Hong KC, Kim YB, Lee JH, Suh CH (2001) Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221:740–746PubMedCrossRef
25.
Zurück zum Zitat Smith TA, Glaholm J, Leach MO, Machin L, McCready VR (1991) The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy. NMR Biomed 4:262–267PubMedCrossRef Smith TA, Glaholm J, Leach MO, Machin L, McCready VR (1991) The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy. NMR Biomed 4:262–267PubMedCrossRef
26.
Zurück zum Zitat Cadoux-Hudson TA, Blackledge MJ, Rajagopalan B, Taylor DJ, Radda GK (1989) Human primary brain tumour metabolism in vivo: a phosphorus magnetic resonance spectroscopy study. Br J Cancer 60:430–436PubMed Cadoux-Hudson TA, Blackledge MJ, Rajagopalan B, Taylor DJ, Radda GK (1989) Human primary brain tumour metabolism in vivo: a phosphorus magnetic resonance spectroscopy study. Br J Cancer 60:430–436PubMed
27.
Zurück zum Zitat Smith TA, Glaholm J, Leach MO, Machin L, Collins DJ, Payne GS, McCready VR (1991) A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer 63:514–516PubMed Smith TA, Glaholm J, Leach MO, Machin L, Collins DJ, Payne GS, McCready VR (1991) A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer 63:514–516PubMed
28.
Zurück zum Zitat Longo R, Pollesello P, Ricci C (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281–285PubMedCrossRef Longo R, Pollesello P, Ricci C (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281–285PubMedCrossRef
29.
Zurück zum Zitat Thomsen C, Becker U, Winkler K (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487–495PubMedCrossRef Thomsen C, Becker U, Winkler K (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487–495PubMedCrossRef
Metadaten
Titel
Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla
verfasst von
F. Fischbach
T. Schirmer
M. Thormann
T. Freund
J. Ricke
H. Bruhn
Publikationsdatum
01.11.2008
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 11/2008
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-008-1040-8

Weitere Artikel der Ausgabe 11/2008

European Radiology 11/2008 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.